Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gigacloud Technology Inc (GCT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Gigacloud Technology IncTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Gigacloud Technology Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Gigacloud Technology Inc trades at $52.01 (market cap $1.84B), while State Street SPDR S&P Biotech ETF trades at $159.35. Which is the better fit depends on your goals.

GCTXBI
Market Cap
$1.84B
Sector
TechnologyBroad Market / Factor
52-Week High
$53.25$164.28
52-Week Low
$25.44$86.92
Enterprise Value
$1.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gigacloud Technology Inc

GigaCloud Technology (GCT) trades at $51.66, up 0.02% on the day, with a bullish technical outlook supported by moving averages and strong support at $50. The company reported Q2 2026 EPS of $1.16, beating estimates, and maintains a 10.65% net income margin. Revenue growth is projected to rise from $1.29B in 2025 to $1.5B in 2026, with consistent profitability.

The stock presents a compelling opportunity with attractive valuations (P/E 12.25, P/S 1.3) and robust fundamentals, though overbought RSI levels near 84 suggest near-term consolidation risk. Analyst consensus is bullish with 67% buy ratings, but investors should monitor execution risks in European expansion and furniture market volatility.

State Street SPDR S&P Biotech ETF

XBI, the SPDR S&P Biotech ETF, trades at $159.39, up 0.86% on the day, with a bullish technical signal driven by moving averages. The fund holds 155 biotech stocks, benefiting from strong sector momentum, including a 17% gain in June 2026 (ETF Trends, 2026-07-01). Recent news highlights institutional buying and positive drug trial outcomes fueling the rally.

Outlook: Biotech sector tailwinds from M&A, AI drug discovery, and clinical successes support further upside, but high volatility and policy risks persist. Investors gain diversified exposure to small- and mid-cap biotech innovation, though the 0.35% expense ratio and lack of dividend yield may deter income-focused buyers.

Returns comparison

Trailing returns across standard periods

About Gigacloud Technology Inc

Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.

Read more on GCT

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI